BACKGROUND: Data on outcome of Stanford type A aortic dissection (TAAD) in Marfan syndrome (MFS) patients are limited. We investigated the full spectrum of reoperation and survival after initial surgery in MFS patients who suffered TAAD. METHODS: Retrospective analysis of 85 consecutive MFS patients in one-single center during the past 15 years. RESULTS: Overall, 85 MFS patients with TAAD underwent surgical repair [74% acute dissections; 80% DeBakey type I; 91% composite valved graft; 70% total arch replacement (TAR); 68% frozen elephant trunk (FET); 7% in-hospital mortality] at Changhai hospital affiliated to the Second Military Medical University over the past 15 years. Five (20.8%) patients in non-TAR group need aortic arch reintervention with resternotomy during follow-up, which is significantly higher than that in TAR group (P=0.001). Freedom from aortic arch reoperation in non-TAR group was all 78.7%±8.5% at 5, 10, and 15 years. No patient required aortic arch reoperation in TAR group (P=0.001). On the other hand, the FET was inserted into false lumen intentionally at initial surgery in 2 cases of chronic TAAD with narrowed true lumen. Scheduled thoracoabdominal aortic replacement was performed 6 months later. Both 2 patients are with well clinical outcomes. At last, we found that Debakey type and TAR at initial surgery were irrelevant to survival and reoperation for descending aorta. CONCLUSIONS: TAR combined with FET is recommended in MFS patients when the aortic arch is dissected or enlarged. The FET could be inserted into the false lumen intentionally in selective case for scheduled 2-staged descending aortic repair. 2019 Journal of Thoracic Disease. All rights reserved.
BACKGROUND: Data on outcome of Stanford type A aortic dissection (TAAD) in Marfan syndrome (MFS) patients are limited. We investigated the full spectrum of reoperation and survival after initial surgery in MFS patients who suffered TAAD. METHODS: Retrospective analysis of 85 consecutive MFS patients in one-single center during the past 15 years. RESULTS: Overall, 85 MFS patients with TAAD underwent surgical repair [74% acute dissections; 80% DeBakey type I; 91% composite valved graft; 70% total arch replacement (TAR); 68% frozen elephant trunk (FET); 7% in-hospital mortality] at Changhai hospital affiliated to the Second Military Medical University over the past 15 years. Five (20.8%) patients in non-TAR group need aortic arch reintervention with resternotomy during follow-up, which is significantly higher than that in TAR group (P=0.001). Freedom from aortic arch reoperation in non-TAR group was all 78.7%±8.5% at 5, 10, and 15 years. No patient required aortic arch reoperation in TAR group (P=0.001). On the other hand, the FET was inserted into false lumen intentionally at initial surgery in 2 cases of chronic TAAD with narrowed true lumen. Scheduled thoracoabdominal aortic replacement was performed 6 months later. Both 2 patients are with well clinical outcomes. At last, we found that Debakey type and TAR at initial surgery were irrelevant to survival and reoperation for descending aorta. CONCLUSIONS: TAR combined with FET is recommended in MFS patients when the aortic arch is dissected or enlarged. The FET could be inserted into the false lumen intentionally in selective case for scheduled 2-staged descending aortic repair. 2019 Journal of Thoracic Disease. All rights reserved.
Entities:
Keywords:
Marfan syndrome (MFS); aortic root surgery; frozen elephant trunk (FET); total arch replacement (TAR); type A aortic dissection (TAAD)
Authors: Joseph S Coselli; Irina V Volguina; Scott A LeMaire; Thoralf M Sundt; Heidi M Connolly; Elizabeth H Stephens; Hartzell V Schaff; Dianna M Milewicz; Luca A Vricella; Harry C Dietz; Charles G Minard; D Craig Miller Journal: J Thorac Cardiovasc Surg Date: 2014-02-08 Impact factor: 5.209
Authors: Bartosz Rylski; Isabell Hoffmann; Friedhelm Beyersdorf; Michael Suedkamp; Matthias Siepe; Brigitte Nitsch; Maria Blettner; Michael Andrew Borger; Ernst Weigang Journal: Ann Surg Date: 2014-03 Impact factor: 12.969
Authors: Bart L Loeys; Harry C Dietz; Alan C Braverman; Bert L Callewaert; Julie De Backer; Richard B Devereux; Yvonne Hilhorst-Hofstee; Guillaume Jondeau; Laurence Faivre; Dianna M Milewicz; Reed E Pyeritz; Paul D Sponseller; Paul Wordsworth; Anne M De Paepe Journal: J Med Genet Date: 2010-07 Impact factor: 6.318
Authors: Bartosz Rylski; Joseph E Bavaria; Friedhelm Beyersdorf; Emanuela Branchetti; Nimesh D Desai; Rita K Milewski; Wilson Y Szeto; Prashanth Vallabhajosyula; Matthias Siepe; Fabian A Kari Journal: Circulation Date: 2014-03-04 Impact factor: 29.690
Authors: Malakh L Shrestha; Erik Beckmann; Firas Abd Alhadi; Heike Krueger; Fiona Meyer-Bockenkamp; Sebastian Bertele; Nurbol Koigeldiyev; Tim Kaufeld; Felix Fleissner; Wilhelm Korte; Jan Schmitto; Serghei Cebotari; Wolfgang Harringer; Axel Haverich; Andreas Martens Journal: Ann Thorac Surg Date: 2017-12-02 Impact factor: 4.330
Authors: Christian D Etz; Konstadinos A Plestis; Fabian A Kari; Maximilian Luehr; Carol A Bodian; David Spielvogel; Randall B Griepp Journal: Eur J Cardiothorac Surg Date: 2008-06-13 Impact factor: 4.191
Authors: Evaldas Girdauskas; Thomas Kuntze; Michael A Borger; Volkmar Falk; Friedrich Wilhelm Mohr Journal: Ann Thorac Surg Date: 2008-12 Impact factor: 4.330